@ARTICLE{
author={Syrigos Konstantinos|,Abert Istvan|,Andric Zoran G|0000-0002-1495-2729,Bondarenko Igor N|,Dvorkin Mikhail|,Galic Kristina|,Galiulin Rinat|,Kuchava Vladimer|,Sriuranpong Virote|,Trukhin Dmytro|,Zhavrid Edvard|,Fu Dongyue|,Kassalow Laurent M|,Jones Stephanie|,Bashir Zahid|},
year={2021},
title={Efficacy and Safety of Bevacizumab Biosimilar FKB238 Versus Originator Bevacizumab: Results from AVANA, a Phase III Trial in Patients with Non-Squamous Non-Small-Cell Lung Cancer (non-sq-NSCLC)},
journal={BIODRUGS},
volume={35},
number={4},
pages={417-428},
document_type={Article},
} 

@ARTICLE{
author={Thongprasert Sumitra|,Geater Sarayut L|,Clement Dana|,Abdelaziz Amr|,Reyes-Igama Jasmin|,Jovanovic Dragana D|,Alexandru Aurelia|,Schenker Michael|,Sriuranpong Virote|,Serwatowski Piotr|,Suresh Sheethal|,Cseh Agnieszka|,Gaafar Rabab|},
year={2019},
title={Afatinib in locally advanced/metastatic NSCLC harboring common <i>EGFR</i> mutations, after chemotherapy: a Phase IV study},
journal={LUNG CANCER MANAGEMENT},
volume={8},
number={3},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Thongprasert Sumitra|,Geater SL|,Clement D|,Abdelaziz A|,Reyes-Igama J|,Jovanovic D|,Alexandru A|,Schenker Michael|,Sriuranpong Virote|,Serwatowski P|,Suresh S|,Cseh Agnieszka|,Gaafar Rabab|},
year={2018},
title={Afatinib in chemotherapy pre-treated EGFR mutation-positive NSCLC},
journal={ANNALS OF ONCOLOGY},
volume={29},
number={},
pages={146-146},
document_type={Meeting Abstract},
}